Clinical Trial Update: Optimal Duration of Anticoagulation in Deep Venous Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the optimal duration of anticoagulation for deep vein thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Lower Extremity Deep Vein Thrombosis

Snippet

Sponsor: University of Padova | Conditions: Deep Vein Thrombosis of Lower Limb, Lower Extremity Deep Venous Thrombosis Recurrent | Phase 3 | Status: COMPLETED